SCHEDULE 13G/A: Disciplined Growth Investors Discloses 11.7% Stake in Core Laboratories

Disciplined Growth Investors, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 11.7% of Core Laboratories Inc.'s common stock as of March 31, 2025.

Summary

• Disciplined Growth Investors, Inc., an investment adviser based in Minneapolis, MN, has filed an Amendment No. 2 to Schedule 13G regarding its beneficial ownership in Core Laboratories Inc. /DE/.
• As of March 31, 2025, Disciplined Growth Investors, Inc. beneficially owns an aggregate of 5,491,722 shares of Core Laboratories Inc. common stock.
• This ownership represents 11.7% of the total class of securities.
• The reporting person holds sole voting power over 4,994,068 shares and sole dispositive power over all 5,491,722 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: This is a routine beneficial ownership disclosure filing (Schedule 13G) and does not contain information that inherently indicates positive or negative sentiment regarding the company's performance or outlook. It simply reports an existing stake.

Positives

• The disclosure of a significant stake by an investment adviser like Disciplined Growth Investors may signal confidence in Core Laboratories Inc. from institutional investors.

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing is a routine disclosure of beneficial ownership by an institutional investor and does not provide specific insights into broader industry trends or competitive dynamics within the oilfield services sector where Core Laboratories operates.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, potentially influencing investor confidence and market perception.

Key Dates

Keywords

Core Laboratories Inc., Disciplined Growth Investors, Schedule 13G, beneficial ownership, common stock, investment adviser, institutional ownership, SEC filing